Skip to content

Correlation between changes in serological indicators and NCCL-s progression after elective PCI in patients with coronary heart disease

Correlation between changes in serological indicators and NCCL-s progression after elective PCI in patients with coronary heart disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115234
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-12-31
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease, Angina pectoris

Interventions

Non-culprit lesion progression group:None
Non-culprit lesion non-progression group:None

Sponsors

Shiyan People's hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria: Patients who underwent CAG at our hospital between January 2019 and December 2023, with at least one major coronary artery confirmed to have luminal stenosis >75%, and who subsequently underwent successful elective PCI, followed by repeat CAG at our hospital after an interval of 6 months or longer; 2.Patients with complete medical records, all of whom received drug-eluting stent implantation during the initial CAG procedure and were administered standard secondary preventive medications for coronary heart disease.

Exclusion criteria

Exclusion criteria: 1.Patients for whom the first-admission PCI was not their initial PCI procedure; 2.Patients with lesions >=75% in all major vessels (left anterior descending artery, right coronary artery, left circumflex artery, or left main artery) as indicated by the first CAG, and who underwent stent implantation; 3.Patients allergic to the contrast agent used during the PCI procedure; 4.Patients with a history of hematological disorders, malignant tumors, congenital heart disease, valvular heart disease, immune system diseases, or other related conditions; 5.Patients who did not regularly take secondary preventive medications for coronary heart disease; 6.Patients with incomplete clinical or coronary angiography data, or poor compliance; 7.Patients diagnosed with acute myocardial infarction during the first admission and undergoing emergency PCI.

Design outcomes

Primary

MeasureTime frame
Blood Lipid Profiles;

Secondary

MeasureTime frame
Serum Albumin;Renal Function.;Albumin-to-Globulin Ratio;Serum Uric Acid;Complete Blood Count;Coagulation Function;Total Bilirubin;

Countries

China

Contacts

Public ContactZhang Zhixin

Shiyan People's hospital

317892976@qq.com+86 719 8637035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026